Community Practice

Latest News


CME Content


HIPAA in Wonderland

In which a determined pharmacist battles the forces of ignorance and stupidity on behalf of his patient and his own sanity.

Patients should decide how a pharmacy can best communicate with patients. And they can use a very American way to make their feelings known.

A New York legislator said he plans to introduce a bill aimed at preventing an Upper East Side pharmacy from charging 9/11 responders $150 to obtain printouts of their records.

FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.

Pharmacists delivering patient care services as part of patient-centered, interdisciplinary healthcare teams can make a difference for diabetes patients who are disproportionately affected by the disease and have limited access to quality care, according to the final results of Project IMPACT: Diabetes.

FDA has approved dulaglutide (Trulicity, Eli Lilly) to treat type 2 diabetes mellitus. The drug is a once-weekly subcutaneous injection used to improve glycemic control and is indicated as an adjunct to diet and exercise in the management of type 2 diabetes in adults.

Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.